Work

Ab0913 Efficacy of Certolizumab Pegol in Preventing Anterior Uveitis Flares Compared With Standard Non-biologic Treatment: a Matched Control Study in High-risk Patients With Axial Spondyloarthritis

Year: 2024

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2024-eular.2614

Authors: N. Haroon, Z. Baskurt, T. Chim, R. Inman, D. Paez, T. Kumke, R. Tham, M. Kim, I. Van der Horst-Bruinsma, L.S. Gensler

Institutions: University of Toronto, Schroeder Arthritis Institute, University Health Network, University of California, San Francisco, UCB Pharma (Germany), UCB Pharma (United Kingdom), UCB Pharma (United States), Radboud University Medical Center

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399484604

Cites:

Cited by:

Related to: 10